Nurulimab

Nurulimab
NEW
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-T77103-1mg 1 mg - - -

7 - 10 business days*

186.00€
TGM-T77103-10mg 10 mg - - -

7 - 10 business days*

784.00€
TGM-T77103-25mg 25 mg - - -

7 - 10 business days*

1,165.00€
TGM-T77103-50mg 50 mg - - -

7 - 10 business days*

1,564.00€
 
Description: Nurulimab (BCD-145) is an anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) human... more
Product information "Nurulimab"
Description: Nurulimab (BCD-145) is an anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) human monoclonal antibody with anti-cancer activity for the study of skin and musculoskeletal diseases. Target: Immunology/Inflammation related, Others. References: International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 34, No. 1, 2020.
Keywords: BCD-145 , BCD145
Supplier: TargetMol
Supplier-Nr: T77103

Properties

Database Information

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Nurulimab"
Write a review
or to review a product.
Viewed